Cormorant Asset Management, LP 的 Form 4 申報
Immuneering CorpIMRX，2024/3/18 申報
- 申報編號
- 0000929638-24-001046
- 申報時間
- 2024/3/18 17:59 ET
- 交易日
- 2024/3/14-3/15
- 申報延遲
- 4 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 5 筆非衍生性交易。公開市場賣出合計 $274.9 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Cormorant Asset Management, LPCIK 0001583977 | 持股 10% 以上大股東 |
| Chen BihuaCIK 0001599214 | 持股 10% 以上大股東 |
| Cormorant Global Healthcare Master Fund, LPCIK 0001618442 | 持股 10% 以上大股東 |
| Cormorant Private Healthcare Fund III LPCIK 0001817320 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/3/14 | Class A Common Stock | S賣出處分 | −345,266 | $3.24F1 | −$1,116,935.51 | 3,859,098 | 間接 | |
| 2024/3/14 | Class A Common Stock | S賣出處分 | −98,570 | $4.25F4 | −$418,429.65 | 3,760,528 | 間接 | |
| 2024/3/14 | Class A Common Stock | S賣出處分 | −54,215 | $5.37F6 | −$291,351.41 | 3,706,313 | 間接 | |
| 2024/3/14 | Class A Common Stock | S賣出處分 | −11,040 | $5.97F8 | −$65,886.72 | 3,695,273 | 間接 | |
| 2024/3/15 | Class A Common Stock | S賣出處分 | −400,000 | $2.14F10 | −$856,400 | 3,295,273 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Represents the weighted average sale price of shares of Class A Common Stock sold in a series of open market transactions on the transaction date at prices ranging from $2.90 to $3.895 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission (the "SEC"), the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. All of these shares were sold by the Master Fund (as defined below).
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents the weighted average sale price of shares of Class A Common Stock sold in a series of open market transactions on the transaction date at prices ranging from $3.90 to $4.895 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. All of these shares were sold by the Master Fund.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents the weighted average sale price of shares of Class A Common Stock sold in a series of open market transactions on the transaction date at prices ranging from $4.90 to $5.89 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. All of these shares were sold by the Master Fund.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents the weighted average sale price of shares of Class A Common Stock sold in a series of open market transactions on the transaction date at prices ranging from $5.90 to $6.18 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. All of these shares were sold by the Master Fund.
表 I 有 1 筆交易的價格引用這則附註。
- F10
Represents the weighted average sale price of shares of Class A Common Stock sold in a series of open market transactions on the transaction date at prices ranging from $1.90 to $2.82 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. All of these shares were sold by the Master Fund.
表 I 有 1 筆交易的價格引用這則附註。